アミオトロフィック横筋硬化症と一般的な癌のリスク:メンデルのランダム化因果関係と媒介の尋問
PubMedで要約を見る
まとめ
この要約は機械生成です。アミオトロフィック横筋硬化症 (ALS) は結腸直腸がん (CRC) のリスクを因果的に低下させる可能性があります. この遺伝学的な研究では 他のがんとの関連性が見出されず,ALSとCRCの間の特定の逆関係を示唆しています.
科学分野
- 神経科学
- 腫瘍学
- 遺伝学
背景
- 神経退行性疾患と癌の逆併発性は文書化されているが,アミオトロフィック横筋硬化症 (ALS) との関連は不明である.
- ALSと癌の因果関係を理解することは,病気の予防と治療戦略にとって極めて重要です.
研究 の 目的
- 結腸直腸がん (CRC) を含む様々な癌との潜在的因果関係を調査する.
- ALS と CRC の関連性における高脂血症などの血清脂質特性の仲介的役割を調査する.
主な方法
- ALSと9つの一般的な固体癌の全ゲノム関連研究 (GWAS) の概要統計を用いたメンデルのランダム化 (MR) 分析.
- MR-Egger,MR-PRESSO,CochranのQテストを含む,逆変数加重 (IVW) 方法と補完的な感度分析を使用した.
- ALSとCRCの関連性における高脂血症の役割を評価するために,MRベースのメディエーション分析を行った.
主要な成果
- 遺伝的に予測されたALSは,ヨーロッパと東アジアの集団におけるCRCのリスクの減少と因果的に関連していました.
- ALSと全体的な癌または他の特定の癌の間の有意な因果関係は見つかりませんでした.
- 媒介分析により,高脂血症はALSによるCRCリスクに間接的に影響することが示唆された.
結論
- 遺伝的に代理されたALSは,神経退行性疾患とがんの相互作用に関する新しい洞察を提供して,CRCのリスクの減少と因果関係がある可能性があります.
- この発見は,神経変性疾患と癌の逆併発性と病因関係を理解するのに寄与する.
関連する概念動画
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...

